LB-100 is a selective catalytic PP2A inhibitor. It affects Wnt/β-catenin and mTORC1 signaling pathways, and by inhibiting PP2A enzymatic activity, it inhibits tumor proliferation and EMT, and promotes immune cell activation.
LB-100: Mechanism of Action
LB-100 MOA：Targeting PP2A/PD-1 Pathway for Cancer Immunotherapy Combination
Jump to
- LB-100 Clinical Trials
- LB-100 Working Concentration | Cell Culture | Treatment
- LB-100 Solubility in DMSO
- LB-100 Stock Solution
- LB-100 Storage
- LB-100 Stability
- LB-100 Combination Database
- LB-100 Molecular Weight
- LB-100 SMILES
- LB-100 CAS Number
- LB-100 Chemical Structure (2D and 3D)
- LB-100 IC50 for Cell-based and Cell-free Assays
- LB-100 Sigma (XPIH9BCF735D)? Try a better option.
- LB-100 MedChemExpress (HY-18597)? Try a better option.
- LB-100 Cayman (29105)? Try a better option.
- LB-100 APExBIO (B4846)? Try a better option.
- LB-100 SDS｜MSDS